日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancer

肿瘤浸润性自然杀伤细胞谱分析在可切除非小细胞肺癌患者治疗分层中的应用

期刊:
影响因子:
doi:10.64898/2026.01.01.696292
Ito, Atsushi; Kang, Sung Wook; Jang, Hee-Jin; Shim, Ji Seon; Lee, Claire; Ranchod, Priyanka; Lee, Gena; Mitra, Sonali; Jeon, Jiyeon; Syarif, Ayu H; Zhang, Yun; Byun, Jinyoung; Han, Younghun; Malo, Joshua; Patel, Meera; Ripley, R Taylor; Groth, Shawn S; Kheradmand, Farrah; Burt, Bryan M; Polverino, Francesca; Amos, Christopher I; Lee, Hyun-Sung
肺癌
肿瘤
肿瘤免疫
自然杀伤细胞
细胞生物学
发表日期：2026
文献求助 收藏

Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma.

Ad-SGE-DKK3 基因疗法克服了胸膜间皮瘤对免疫检查点阻断的耐药性

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-4024
Jang Hee-Jin, Patel Meera, Wang Daniel Y, Kang Sung Wook, Choi Jong Min, Lee Claire, Vilchis Monica, Shim Ji Seon, Mitra Sonali, Ranchod Priyanka, Kuncheria Allen, Hudson William, Jindra Peter, Lenge De Rosen Veronica, Ramineni Maheshwari, Camp Ernest Ramsay, Kheradmand Farrah, Ripley R Taylor, Groth Shawn S, Lee Hyun-Sung, Burt Bryan M
免疫/内分泌
发表日期：2025
文献求助 收藏

Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy

可溶性间皮素相关肽作为接受免疫检查点疗法的胸膜间皮瘤患者的预后指标

期刊:Journal of Thoracic and Cardiovascular Surgery
影响因子:4.4
doi:10.1016/j.jtcvs.2024.10.005
Mitra, Sonali; Jang, Hee-Jin; Kuncheria, Allen; Kang, Sung Wook; Choi, Jong Min; Shim, Ji Seon; Lee, Claire; Ranchod, Priyanka; Jindra, Peter; Ramineni, Maheshwari; Patel, Meera; Ripley, R Taylor; Groth, Shawn S; Blackmon, Shanda H; Burt, Bryan M; Lee, Hyun-Sung
免疫/内分泌
发表日期：2025
文献求助 收藏

The state of educational research in cardiothoracic surgery: A review of the literature

心胸外科教育研究现状：文献综述

期刊:JTCVS Open
影响因子:1.9
doi:10.1016/j.xjon.2025.10.010
Shekar, Amirtha; Hart, Victoria; Treffalls, John; Miles, Travis J; Rosengart, Todd K; Moon, Marc R; Coselli, Joseph S; Barron, Lauren M; Groth, Shawn S; Blackmon, Shanda H; Ghanta, Ravi K; Hui, Dawn S; Chatterjee, Subhasis
发表日期：2025
文献求助 收藏

Clinical staging to differentiate T2 and T3 esophageal squamous cell carcinomas-essential details or just noise?

临床分期在区分T2和T3期食管鳞状细胞癌中的作用——是关键细节还是无关信息？

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-24-491
Groth, Shawn S
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Breaking through the chest wall: the prognostic significance of rib invasion in lung cancer surgery

突破胸壁：肋骨侵犯在肺癌手术中的预后意义

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-23-633
Jafferji, Mohammad S; Groth, Shawn S
肺癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Commentary: Adjuvant chemotherapy after trimodal therapy for esophageal carcinoma: A bitter pill to swallow

评论：食管癌三联疗法后的辅助化疗：苦药难咽

期刊:JTCVS Open
影响因子:1.9
doi:10.1016/j.xjon.2020.12.013
Du, Valerie X; Groth, Shawn S
食管癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Commentary: One system to rule them all

评论：一个体系统治一切

期刊:JTCVS Open
影响因子:1.9
doi:10.1016/j.xjon.2021.05.004
Du, Valerie X; Groth, Shawn S
发表日期：2021
文献求助 收藏

Percentage of tumor-infiltrating lymphocytes after chemoradiation therapy for locally advanced esophageal squamous cell carcinoma: a biomarker for pathological response rates and cancer-specific survival?

局部晚期食管鳞状细胞癌放化疗后肿瘤浸润淋巴细胞百分比：病理反应率和癌症特异性生存率的生物标志物？

期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm.2019.10.25
Groth, Shawn S; Burt, Bryan M
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Future directions in esophageal cancer therapy

食管癌治疗的未来方向

期刊:Annals of Cardiothoracic Surgery
影响因子:3.1
doi:10.21037/acs.2017.02.01
Wald, Ori; Smaglo, Brandon; Mok, Henry; Groth, Shawn S
食管癌
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏